Primary Immune Deficiency Clinical Trials

29 clinical trials for Primary Immune Deficiency across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death — RECRUITING
• Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies — RECRUITING
• Biologics And Clinical Immunology Cohort at Sinai — RECRUITING
• COVID-19 in PID Survey — RECRUITING
• Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) — OTHER · PHASE3
• Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) — OTHER · PHASE3
• Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases — ACTIVE_NOT_RECRUITING · PHASE3
• Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases — NOT_YET_RECRUITING · PHASE2
• Primitive Immunodeficiency and Pregnancy — COMPLETED
• Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults — COMPLETED
• Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies — COMPLETED
• Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency — ACTIVE_NOT_RECRUITING · PHASE3
• COVID-19 Vaccine Responses in PIDD Subjects — ACTIVE_NOT_RECRUITING
• Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICF — COMPLETED
• Evaluating Bronchodilator Response in Patients With Bronchiectasis — OTHER · NA
• An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD) — OTHER · PHASE4
• A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) . — OTHER · NA
• Antibody Production in Immune Disorders — TERMINATED · PHASE4
• Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation — OTHER · PHASE1
• Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules — COMPLETED · PHASE4
• A PROSPECTIVE, OPEN-LABEL, MULTICENTER STUDY OF THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF THERAPURE PLASMACAP IG IN ADULTS AND CHILDREN WITH PRIMARY IMMUNE DEFICIENCY DISEASES — COMPLETED
• Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood — OTHER
• Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) — COMPLETED · PHASE3
• Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) — COMPLETED · PHASE3
• Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) — COMPLETED · PHASE3
• Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency — COMPLETED · PHASE3
• Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy — COMPLETED · PHASE3
• Ig NextGen 10% in Patients With Primary Immune Deficiency (PID) — COMPLETED · PHASE3
• Retrospective Chart Review of Subcutaneous IgG Use in Infants — COMPLETED

Refine this search